Supriya Lifescience shares surge 17% on strong Q4 earnings; PAT rises 47% YoY

Supriya Lifescience shares jumped over 16% after the company posted a strong Q4FY26 performance, with PAT rising 47% YoY and revenue surging 50%. Robust demand across therapeutic segments, improved capacity utilisation, and traction in regulated markets supported growth. The stock remains in an uptrend despite overbought technical indicators.

Wockhardt shares jump 8%, extend rally after CDSCO nod for Zaynich antibiotic

Wockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial results and the drug’s potential to treat severe drug-resistant infections boosted investor sentiment, helping the stock extend recent gains despite technically entering overbought territory after a sharp rally.

Infosys, Wipro, TCS, other IT stocks jump up to 4%: What’s behind the bullish sentiment in a muted market?

IT stocks, including Infosys and TCS, surged up to 4% on Friday, driven by Wipro’s expanded partnership with ServiceNow to scale AI workflows. This collaboration aims to integrate Wipro Intelligence with ServiceNow’s AI Platform, streamlining enterprise operations and accelerating AI adoption. The move boosted investor confidence in Indian IT companies, despite earlier concerns about AI […]

Anthropic eclipses OpenAI with valuation of $965 billion

Anthropic PBC has raised funding at a $965 billion valuation, overtaking rival OpenAI for the first time. The round was led by Altimeter Capital, Dragoneer, Greenoaks and Sequoia Capital, with each investing over $2 billion. Google and Amazon also joined as part of previously announced multibillion-dollar commitments to Anthropic.